N-Nitroso Amitriptyline EP Impurity C
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Nortriptyline is indicated for use in the treatment of depression (FDA-approved). It can also be used off-label for conditions such as chronic pain, diabetic neuropathy, myofascial pain, orofacial pain, and postherpetic neuralgia. Nortriptyline has also shown to be useful in patients trying to quit smoking. N-Nitroso Nortriptylin is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline is also known as N-Nitroso N-Desmethyl Amitriptyline & N-Nitroso Amitriptyline EP Impurity C . It is chemically represented as N-(3-(10,11-dihydro-5H-dibenzo[a,d].[7]annulen-5-ylidene)propyl)-Nmethylnitrous amide . Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline . We supply N-Nitroso Nortriptyline with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141620 |
| CAS No | NA |
| Mol.F. | C16H17FN4O3 |
| Mol.Wt. | 332.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141621 |
| CAS No | NA |
| Mol.F. | C16H18FN3O3S |
| Mol.Wt. | 351.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141622 |
| CAS No | NA |
| Mol.F. | C21H25FN4O7S |
| Mol.Wt. | 496.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141623 |
| CAS No | NA |
| Mol.F. | C13H18N2O4 |
| Mol.Wt. | 266.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141624 |
| CAS No | NA |
| Mol.F. | C26H38N4O7 |
| Mol.Wt. | 518.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141625 |
| CAS No | NA |
| Mol.F. | C26H38N4O7 |
| Mol.Wt. | 518.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141626 |
| CAS No | NA |
| Mol.F. | C14H22N2O4 |
| Mol.Wt. | 282.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141627 |
| CAS No | NA |
| Mol.F. | C12H18N2O3 |
| Mol.Wt. | 238.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141628 |
| CAS No | NA |
| Mol.F. | C13H20N2O3 |
| Mol.Wt. | 252.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141629 |
| CAS No | NA |
| Mol.F. | C13H18N2O4 |
| Mol.Wt. | 266.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141630 |
| CAS No | NA |
| Mol.F. | C26H39N3O6 |
| Mol.Wt. | 489.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141631 |
| CAS No | NA |
| Mol.F. | C13H20N2O2 |
| Mol.Wt. | 236.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141632 |
| CAS No | NA |
| Mol.F. | C20H26N2O4 |
| Mol.Wt. | 358.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141633 |
| CAS No | NA |
| Mol.F. | C13H17ClN2O4 |
| Mol.Wt. | 300.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141634 |
| CAS No | NA |
| Mol.F. | C13H19ClN2O4 |
| Mol.Wt. | 302.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141635 |
| CAS No | NA |
| Mol.F. | C14H22N2O4 |
| Mol.Wt. | 282.3 |
| INV STATUS | CUSTOM SYNTHESIS |